Improvement in visual function assessment
| Worse VFA (n=40) | Same VFA (n=7) | Improved VFA (n=123) | p Value* | |
|---|---|---|---|---|
| *Significance levels were calculated (t test) by comparing the patients who improved with those that did not. | ||||
| Diagnosis | ||||
| Corneal degeneration | 1 (14.3%) | 6 (85.7%) | ||
| Trauma | 2 (28.6%) | 5 (71.4%) | ||
| Scar/oedema | 2 (15.4%) | 11 (84.6%) | ||
| Fuchs' | 8 (29.6%) | 1 (3.7%) | 18 (66.7%) | |
| Keratitis | 2 (13.3%) | 2 (13.3%) | 11 (73.3%) | |
| Keratoconus | 4 (23.5%) | 13 (76.5%) | ||
| PBK/ABK | 15 (24.6%) | 3 (4.9%) | 43 (70.5%) | |
| Regraft | 5 (22.7%) | 1 (4.5%) | 18 (72.2%) | 0.915 |
| Preop visual acuity (best corrected) | ||||
| ≥20/40 | 22 (23.4%) | 6 (6.4%) | 66 (70.2%) | |
| 20/60–20/80 | 6 (20.0%) | 24 (80.0%) | ||
| 20/100–20/200 | 5 (17.9%) | 1 (3.6%) | 22 (78.6%) | |
| <20/200 | 2 (25.0%) | 6 (75.0%) | 0.761 | |
| Postop visual acuity (best corrected) | ||||
| ≥20/40 | 27 (22.7%) | 5 (4.2%) | 87 (73.1%) | |
| 20/60–20/80 | 4 (23.5%) | 13 (76.5%) | ||
| 20/100–20/200 | 8 (100.0%) | |||
| <20/200 | 4 (50.0%) | 1 (12..5%) | 3 (37.5%) | 0.169 |
| Mean age (SD) | 68.5 (15.6) | 68.8 (17.7) | 66.8 (17.4) | 0.849 |
| Sex | ||||
| Female | 21 (20.2%) | 4 (3.8%) | 79 (76.0%) | |
| Male | 19 (28.8%) | 3 (4.5%) | 44 (66.7%) | 0.407 |
| Preop pain | ||||
| None | 22 (22.2%) | 4 (4.0%) | 73 (73.7%) | |
| Intermittent | 12 (23.5%) | 3 (5.9%) | 36 (70.6%) | |
| Constant | 6 (30.0%) | 14 (70.0%) | 0.79 | |
| Mean preop VFA (SD) | 67.5 (24.1) | 88.0 (15.8) | 61.7 (24.6) | 0.014 |
| Mean priority points (SD) | 39.1 (24.0) | 20.8 (9.4) | 36.4 (21.1) | 0.123 |